Ticker > Company >

Artemis Medicare share price

Artemis Medicare Services Ltd.

NSE: ARTEMISMED BSE: 542919 SECTOR: Hospital & Healthcare Services  52k   66   15

260.40
+0.10 (0.04%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 260.4

Today's Low

₹ 253.1

52 Week High

₹ 348.3

52 Week Low

₹ 173

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

3617.8 Cr.

Enterprise Value

3798.06 Cr.

No. of Shares

13.89 Cr.

P/E

43.35

P/B

4.68

Face Value

₹ 1

Div. Yield

0.17 %

Book Value (TTM)

₹  55.67

CASH

57.94 Cr.

DEBT

238.21 Cr.

Promoter Holding

67.17 %

EPS (TTM)

₹  6.01

Sales Growth

18.32%

ROE

13.88 %

ROCE

16.48%

Profit Growth

23.84 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year18.32%
3 Year28.1%
5 Year9.11%

Profit Growth

1 Year23.84%
3 Year90.7%
5 Year18.89%

ROE%

1 Year13.88%
3 Year12.91%
5 Year10.08%

ROCE %

1 Year16.48%
3 Year14.08%
5 Year12.24%

Debt/Equity

0.6316

Price to Cash Flow

33.62

Interest Cover Ratio

3.2993

CFO/PAT (5 Yr. Avg.)

2.55932295576664

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 67.17 44.53
Dec 2024 67.17 44.53
Sep 2024 67.17 44.53
Jun 2024 67.51 44.53
Mar 2024 68.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 90.6952484403893% for the Past 3 years.
  • The company has shown a good revenue growth of 28.1028170574572% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -108.6227 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.55932295576664.

 Limitations

  • The company is trading at a high PE of 43.35.
  • Promoter pledging is high as 44.53%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 216.87 216.89 234.67 226.89 234.8
Total Expenditure 180.76 181.22 192.89 190.06 199.26
Operating Profit 36.11 35.68 41.79 36.84 35.54
Other Income 1.87 4.38 7.5 8.8 12.23
Interest 8.08 7.7 7.6 7.65 7.53
Depreciation 10.46 10.22 10.6 10.94 11.25
Exceptional Items 0 0 0 0 0
Profit Before Tax 19.44 22.14 31.08 27.04 29
Tax 5.52 5.22 8.52 6.26 5.79
Profit After Tax 13.92 16.92 22.56 20.78 23.21
Adjusted EPS (Rs) 1.02 1.24 1.64 1.51 1.69

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 563.09 402.06 544.78 714.33 845.23
Total Expenditure 500.85 367.02 478.65 620.55 716.85
Operating Profit 62.24 35.05 66.14 93.78 128.38
Other Income 4.57 3.55 4.92 7.13 7.29
Interest 12.51 12.27 11.17 18.59 29.59
Depreciation 22.33 20.65 21.08 29.47 38.03
Exceptional Items 0 3.23 0 0 0
Profit Before Tax 31.97 8.91 38.81 52.86 68.04
Tax 11.54 1.82 6.23 13.18 18.89
Net Profit 20.43 7.09 32.58 39.69 49.15
Adjusted EPS (Rs.) 1.54 0.54 2.46 2.96 3.62

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 13.24 13.24 13.24 13.41 13.59
Total Reserves 300.83 308.38 348.37 393.01 438.05
Borrowings 60.57 98.77 152.57 198.26 216.49
Other N/C liabilities 49.67 61.42 66.23 104.81 136.01
Current liabilities 156.85 115.68 133.08 197.61 174.27
Total Liabilities 581.16 597.5 713.5 907.09 978.4
Assets
Net Block 387.13 371.82 476.05 583.75 699.23
Capital WIP 55.69 81.01 62.11 94.68 33.45
Intangible WIP 0 0 1.94 0 0
Investments 1.69 4.29 5.59 11.7 15.02
Loans & Advances 19.31 34.43 44.61 57.73 65.98
Other N/C Assets 0.59 0.25 0.57 1.01 0.71
Current Assets 116.75 105.7 122.63 158.23 164.01
Total Assets 581.16 597.5 713.5 907.09 978.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 31.97 8.91 38.81 52.86 68.04
Adjustment 33.84 28.68 36.34 46.44 56.14
Changes in Assets & Liabilities -5.15 -8.17 1.85 32.5 -12.01
Tax Paid -4.17 -2.37 -16.33 -2.45 -4.58
Operating Cash Flow 56.49 27.04 60.67 129.35 107.59
Investing Cash Flow -21.52 -34.08 -106.1 -152.53 -88.97
Financing Cash Flow -33.01 12.73 43.65 29.73 -27.03
Net Cash Flow 1.96 5.69 -1.77 6.55 -8.41

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 68.03 67.51 67.17 67.17 67.17
constructive finance priv... 68.03 67.51 67.17 67.17 67.17
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 31.97 32.49 32.83 32.83 32.83
artemis medicare services... 1.73 1.72 1.71 1.71 1.71
devlina chakravarty - - - 2.57 2.52
governor of kerala 4.97 4.93 4.91 4.91 4.91
kerala state industrial d... 2.21 2.19 2.18 2.18 2.18
llp - - 0.09 0.06 0.05
devlina chakravarty 1.56 2.15 2.57 - -

Annual Reports

Title Action
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020

Ratings & Research Reports

TYPE AGENCY ACTION
Credit CARE
Credit CARE
TYPE AGENCY ACTION
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER ACTION
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER ACTION
Presentation Q4FY24
Presentation Q3FY24
Presentation Q3FY23

Company News

Artemis Medicare Stock Price Analysis and Quick Research Report. Is Artemis Medicare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Artemis Medicare and its performance over the period of time. Artemis Medicare stock price today is Rs 259.05.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Artemis Medicare cash from the operating activity was Rs 107.5927 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Artemis Medicare has a Debt to Equity ratio of 0.6316 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Artemis Medicare , the EPS growth was 22.2549 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Artemis Medicare has OPM of 15.1885910141459 % which is a good sign for profitability.
     
  • ROE: Artemis Medicare have a average ROE of 13.8813 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Artemis Medicare is Rs 259.05. One can use valuation calculators of ticker to know if Artemis Medicare share price is undervalued or overvalued.
Last Updated on:
Brief about Artemis Medicare
X